National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Int J Lab Hematol. 2023 Jun;45(3):337-343. doi: 10.1111/ijlh.14028. Epub 2023 Feb 7.
In this study, we aimed to compare the immunophenotype of tumor cells in children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) harboring rearrangements of the CRLF2 gene with that in children without such aberrations with a specific focus on the surface expression of the related protein thymic stromal lymphopoietin receptor (TSLPR).
We examined bone marrow samples from 46 patients with primary BCP-ALL who had CRLF2 rearrangements detected by FISH (CRLF2(+) cohort). A total of 140 consecutive patients with intact CRLF2 were included in a control CRLF2(-) cohort. TSLPR expression was studied by flow cytometry.
The majority of CRLF2(+) patients were conventionally positive (≥20% positive cells) for TSLPR (33 of 46, 71.7%). Among the remaining children in this group, two were completely TSLPR-negative, seven had less than 10% TSLPR-positive cells, and four had between 10% and 20% TSLPR-positive cells. By contrast, the majority of CRLF2(-) patients had no TSLPR-positive cells (119 of 140, 85.0%), while in 15 cases (10.7%), the percentage of TSLPR-positive cells was below 10%, and in six cases (4.3%), it was between 10% and 20%. Receiver operator characteristic analysis revealed a threshold of only 1.6% TSLPR-positive cells for the effective prediction of the presence of CRLF2 rearrangement. Moreover, this threshold retained its predictive value when only children with low TSLPR positivity were studied.
When surface TSLPR is detected at the diagnosis of BCP-ALL, close attention should be given to the search for chromosomal aberrations involving CRLF2 at any level of expression.
本研究旨在比较伴有 CRLF2 基因重排的儿童 B 细胞前体急性淋巴细胞白血病(BCP-ALL)与无此类异常的儿童肿瘤细胞的免疫表型,特别关注相关蛋白胸腺基质淋巴细胞生成素受体(TSLPR)的表面表达。
我们检测了 46 例经 FISH 检测到 CRLF2 重排的初诊 BCP-ALL 患儿的骨髓样本(CRLF2(+)组)。另外,还纳入了 140 例 CRLF2 完整的连续患者作为对照 CRLF2(-)组。通过流式细胞术研究 TSLPR 的表达。
大多数 CRLF2(+)患者的 TSLPR 表达呈典型阳性(≥20%阳性细胞)(33/46,71.7%)。在该组中其余患儿中,有两名完全 TSLPR 阴性,7 名患儿 TSLPR 阳性细胞比例<10%,4 名患儿 TSLPR 阳性细胞比例为 10%至 20%。相比之下,大多数 CRLF2(-)患者无 TSLPR 阳性细胞(119/140,85.0%),而在 15 例患者(10.7%)中,TSLPR 阳性细胞比例<10%,在 6 例患者(4.3%)中,比例为 10%至 20%。ROC 分析显示,仅需 1.6%的 TSLPR 阳性细胞即可有效预测 CRLF2 重排的存在。此外,当仅研究 TSLPR 低表达阳性的患儿时,该阈值仍具有预测价值。
当在 BCP-ALL 诊断时检测到表面 TSLPR 时,应密切关注任何表达水平的 CRLF2 相关染色体异常的检测。